Fri, March 17, 2023

Jonathan Wolleben Maintained (SPRB) at Buy and Held Target at $7 on, Mar 17th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-7-on-mar-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Jonathan Wolleben of JMP Securities, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $7 on, Mar 17th, 2023.

Jonathan has made no other calls on SPRB in the last 4 months.



There are 2 other peers that have a rating on SPRB. Out of the 2 peers that are also analyzing SPRB, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jonathan


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $8 on, Monday, February 13th, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $8 on, Thursday, November 17th, 2022